Dallas, TX: ReportsandReports announce it will carry Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile Market Research Report in its Store.
Browse complete Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile Report
Introduction
This analysis examines the historical and forecast performance for Mitsubishi Tanabe in the Rx drug sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
- Benchmark Mitsubishi Tanabe’s performance against key rivals in the prescription pharmaceutical sector
- Assess how the merger of Mitsubishi and Tanabe has provided scale, re-focused the company’s strategic priorities and resource capabilities
- Assess how Mitsubishi Tanabe’s launch portfolio is forecast to offset the sluggish sales growth of its aging marketed portfolio
Table of Content
ABOUT DATAMONITOR HEALTHCARE
About the PharmaVitae team
Chapter 1 About this profile
PharmaVitae Explorer database
Chapter structure
Executive summary
Quarterly update
Company introduction
Company sales
Company financials
Key products and competitors
Data sourcing
Sales data
Analyst consensus
Chapter 2 Executive summary
Key findings
Prescription pharmaceutical sales and growth rate performance, 2002-14
Financial performance, 2002-14
Mitsubishi Tanabe: PharmaVitae forecasts at a glance
Mitsubishi Tanabe: PharmaVitae forecasts at a glance
Strategic insight
2002-06: Tanabe’s historical sales driven by Remicade uptake
2007: Tanabe and Mitsubishi merger – amid a wave of Japanese consolidation
2008-14: Greater scale, but slow growth
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Table of Contents
Table of figures
Chapter 3 Quarterly update
Latest prescription pharma product news
Q1 2010
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Q4 2008
Latest corporate news
Q1 2010
Q3 2009
Q2 2009
Q1 2009
Q4 2008
Future product milestones
Chapter 4 Company introduction
Key findings
Background
Key corporate developments
M&A history
Merger of Mitsubishi Pharma and Tanabe Seiyaku
M&A history – Mitsubishi Pharma
Acquired by Mitsubishi Chemical Corporation
Divestment of OTC franchise
Divestment of US plasma fractionation business
M&A history – Tanabe Seiyaku
Animal Health Business Transferred from Tanabe to Dainippon
M&A strategy
Increase in US presence
Strengthen reputation in Japan
Current corporate structure
Pharmaceuticals segment
Other business segment
Chapter 5 Company sales
Key findings
Prescription pharmaceutical sales and growth rate analysis, 2002-14
Product analysis
Product analysis
Product analysis, 2002-08
Product analysis, 2008-14
Therapy area analysis
Geographic analysis
Launch/core/expiry analysis
Explanation of launch/core/expiry analysis
Launch analysis, 2008-14
Core analysis, 2008-14
Expiry analysis, 2008-14
Launch/core/expiry configuration, 2008-14
Molecule type analysis
Externalization analysis
Chapter 6 Company financials
Key findings
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08
Operating costs and profit analysis
Operating costs and profit analysis, 2002-08
Operating cost ratio and profit margin analysis, 2002-08
Operating cost ratio and profit margin analysis, 2008-14
Operating costs and profit analysis, 2008-14
Chapter 7 Appendix
Abbreviations
Exchange rates
About Datamonitor
About Datamonitor Healthcare
Datamonitor consulting
Disclaimer
Browse complete Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile Report
Browse all Healthcare Market Research Reports
Browse all Datamonitor Market Research Reports RSS
Browse all Latest Report
Related Reports:
Mitsubishi Tanabe Pharma Corporation-Company Report
Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation – SWOT Analysis
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/
